In this one-hour webinar, Q&C Services’ regulatory and quality experts will present an analysis of Health Canada’s 2025 inspection activity, translating inspection data into practical insights for pharmaceutical leaders planning for 2026. Drawing on findings from hundreds of Health Canada inspections, this session will highlight the most frequently cited GMP areas across fabricators, importers, distributors, wholesalers, and testers. More importantly, we’ll examine how Health Canada’s focus areas are evolving, and what these shifts mean for risk, resourcing, and inspection readiness. Through this webinar, attendees will be able to move beyond reactive compliance and better prepare their organizations for inspections, market entry, and operational decision-making in 2026.

In this webinar, you will learn:

• The most frequently cited GMP non-conformances observed in Health Canada’s 2025 inspections

• Key trends and shifts in Health Canada’s inspection focus areas

• Where organizations are most exposed to compliance risk and rework

• Practical considerations for inspection readiness and regulatory planning

• Actionable steps leaders can take to strengthen quality and compliance strategies in 2026

—

About Q&C Services

Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural health product, and medical device companies. With 30+ years of experience and a team of 70+ experts, we specialize in Health Canada compliance to help global companies successfully market, import, and sell regulated products in Canada. Trusted by the world’s largest pharmaceutical companies, we offer GMP and regulatory consulting, importing services, product and facility licensing, and commercial consulting services. To date, we have imported more than 750 products, completed over 300 Health Canada audits, and currently maintain more than 500 foreign sites. Let us put our expertise to work for your business. Learn more at www.qualityandcompliance.com.